Re: FDA Drug Advisers Have Financial Conflict of Interest plus more...... by kwanyin ..... News Forum
Date: 2/19/2015 11:00:22 AM ( 6 years ago ago)
Regarding corruption surrounding the recommendation of influenza vaccines; there are no restrictions with regard to conflicts of interest for the employees of the CDC or for those of the FDA (Kuehn, 2010). Each employee of either agency is allowed to own stock in drug companies. There is of course the revolving door. The most blatant example of revolving door corruption may be the action of the former director of the CDC, Julie Gerberding. Gererding blocked the CDC's planned retraction of their recommendation for HPV vaccine after significant numbers of girls had died or been rendered paralyzed by the HPV vaccine. Soon after blocking the retraction, Gerberding was offered and took a position at Merck, the manufacturer of Gardasil, the world's best selling HPV vaccine, as head of Merck Vaccines Department (Reuters, 2009). It is a level of corruption that we would expect to see in only third world countries.
In 1993, the Comprehensive Childhood Immunization Act was signed into law by President Clinton. Among the various provisions of the law is one that provides for between $50 and $100 to be paid by the CDC to school districts for every 'Fully vaccinated' child in their district. Here again, we see the opportunity for corruption. Vaccine manufacturers, their shareholders, including government employees, and school districts have the opportunity to make money for themselves, or for their departments. Certainly employees of school districts won't be 'getting fat' on the CDC's $50 to $100, but clearly there is a greater likelihood that they may lose their job due to cuts if the coercion to have students vaccinated ceases.
from: How the Governmentís Vaccine Policy is Infected by Corruption: http://www.greenmedinfo.com/blog/how-government%E2%80%99s-vaccine-policy-infected-corruption-1
<< Return to the standard message view
fetched in 0.28 sec, referred by curezone.org/forums/fmp.asp?i=2237716